Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes

2014

In pre-clinical mouse models, the interleukin-22 pathway is identified as a novel target for therapeutic intervention in metabolic diseases.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

37

References

262

Citations